The discovery that the lactate dehydrogenase (LDH) of serum and of most tissue extracts consists of five electrophoretically distinct isoenzymes (Vesell and Bearn 1957; Wieland and Pfleiderer, 1957; Sayre and Hill, 1957) has led to important improvements in the diagnostic value of estimation of this enzyme. The isoenzyme patterns observed have a considerable measure of tissue specificity (Nisselbaum and Bodansky, 1959; Plagemann, Gregory, and Wr6b-lewski, 1960) , but as the individual isoenzymes have been shown to differ from each other in some of their chemical and catalytic properties, several methods have been suggested for assessing the isoenzyme composition of a raised serum LDH without recourse to electrophoresis. Of these, determinations of the serum a-hydroxybutyrate dehydrogenase (HBD) (Rosalki and Wilkinson, 1960; Elliott and Wilkinson 1961) and the heatstable lactate dehydrogenase (Plagemann et al., 1961) have found applications in confirming the diagnosis of suspected myocardial infarction, and recent assessments have shown that in uncomplicated cases these tests give results which correlate satisfactorily with those of other procedures (Strandjord, Clayson, and Freier, 1962; Rosalki and Wilkinson, 1964; Preston, Recei-ved Wieland, Pfleiderer, and Ortanderl (1959) to inhibit preferentially the electrophoretically fast isoenzymes, LDH1 and LDH2, and subsequently oxalate was found to have a similar action Emerson, Wilkinson, and Withycombe, 1964 (Richterich and Burger, 1963; Plummer, Wilkinson, and Withycombe, 1963; Withycombe, Plummer, and Wilkinson, 1965 For inhibition studies 6 mM-potassium oxalate or 6 M-urea was made up in 0-067 M-S0rensen phosphate buffer at pH 7-4. The solutions were stored at 4°C. and were freshly prepared at monthly intervals. Oxalate solution (0.1 ml.) or urea solution (1-0 ml.) was incorporated into the reaction mixture of buffer, serum, and nucleotide about 30 minutes before the addition of the substrate. The final inhibitor concentrations were thus 02 mM-oxalate and 2M-urea.
BLOOD SPECIMENS Blood was collected by venepuncture from 16 healthy normal subjects, who served as controls, and from 19 patients who had suffered acute myocardial infarction one to four days previously and in whom the clinical diagnosis was confirmed by electrocardiography and by serum aspartate amino-transferase and HBD determination. Blood samples from five patients with pernicious anaemia showing typical bone marrow changes and from 18 patients with liver diseases were also included in the survey. The liver disease group (diagnoses confirmed by biochemical studies) comprised nine patients with infective hepatitis, two with cirrhosis, two with massive hepatic metatases, two with massive liver necrosis following cardiac arrest or cardiac surgery, and one each of phosphorus poisoning, obstructive jaundice, and acute alcoholism. 100ml.). The serum aspartate and alanine aminotransferases were raised to 43 and 70 i.u./l. respectively and the serum alkaline phosphatase was 22 King-Armstrong units; the serum HBD/LDH ratio was subnormal, and the serum LDH was 80 % inhibited by urea (see below). It was concluded that the patient was convalescing after infective hepatitis. The second exception was a man of 56 with rheumatoid arthritis and clinical jaundice, who had high serum aspartate and alanine aminotransferase levels (220 and 40 i.u./l. respectively), a subnormal serum HBD/LDH ratio, and a serum LDH 70% inhibited by urea.
The effects observed with urea ( Fig. 3) were the reverse of those found with oxalate, for the enzyme in the sera of patients with liver disease was inhibited to a much greater extent than that of normal sera, while with one exception the serum LDH of patients with myocardial infarction or megaloblastic anaemia was comparatively little affected by the presence of inhibitor. The anomalous patient in this group had suffered a typical episode of myocardial infarction: his elevated serum LDH was sensitive to oxalate (72% inhibition), but inhibition by urea of 50% fell in the normal range (Figure 3 ). There was some evidence, however, of coexisting liver damage, since the serum alanine aminotransferase was 45 i.u./l.
The percentage inhibitions obtained with both groups of pathological sera were shown by Student's t test to be significantly different from those observed with the control sera. The mean percentage inhibitions and other statistical data are summarized in Table I . (Fig. 4) The slow isoenzymes, LDH4 and LDH5, are almost completely inhibited by 2M-urea while LDH1 and LDH2 are but little affected (Richterich and Burger, 1963; Plummer et al., 1963; Withycombe et al., 1965) , and urea would be expected to have the opposite effect.
It seems that, as a differential inhibitor of the serum LDH, urea may be of somewhat greater diagnostic value than oxalate, since it gave results which correlated with the diagnoses when applied to the sera which reacted anomalously with oxalate. Nevertheless, since they act in opposite senses, urea and oxalate are complementary to each other as inhibitors of the serum LDH. The results observed with both groups of pathological sera are highly significantly different (P <0 001) from the control values when either of these inhibitors is used, and it therefore seems that determination of the percentage inhibition might well have applications in diagnosis.
More than 68 % inhibition by oxalate and less than 45 % by urea is highly suggestive of cardiac damage, whereas if the urea inhibition is greater than 620% and that by oxalate less than 50%, the liver is likely to be involved. Inhibitor studies have proved particularly useful when the serum HBD/LDH ratio is within the normal range and the diagnosis remains in doubt as, for example, in myocardial infarction complicated by congestive cardiac failure or in suspected liver disease when the dehydrogenase levels remain within the normal range.
As serum is usually diluted 1 in 30 for determinatih n of the LDH it is unlikely that the c ncentration of endogenous urea will ever be high enough to exert any inhibitory action, even in uraemia. Nevertheless, ultrafiltrates of uraemic sera have been shown to contain an inhibitor of rabbit muscle LDH (Morgan, Morgan, and Thomas, 1963) , and in this laboratory we have consistently observed an increase in the serum LDH activity of uraemic patients after dialysis in an artificial kidney. The factor concerned however, has not so far been identified, but it does not appear to be urea.
